Capitol Health (ASX:CAJ) has announced that it has received informal merger clearance from the Australian Competition and Consumer Commission (ACCC) for its proposed merger with Integral Diagnostics Limited (IDX). This clearance is contingent upon the divestment of Capitol's clinic in Melton, Victoria. The merger was initially announced on June 17, 2024.
Capitol Health has received a crucial informal merger clearance from the ACCC for its proposed merger with Integral Diagnostics, contingent upon the divestment of a clinic in Melton, Victoria. With this regulatory hurdle cleared, the company is now seeking final court approval, with a hearing scheduled for December 10, 2024. The merger timeline outlines several key dates, including the effective date on December 11, 2024, and the delisting of Capitol from the ASX on December 23, 2024. Capitol Health continues to engage with shareholders, ensuring they are informed and supported throughout the process. This merger underscores the company's commitment to expanding its footprint and enhancing service delivery in the diagnostic imaging sector.
The ACCC's decision represents a pivotal step in our journey to merge with Integral Diagnostics. We remain committed to fulfilling the necessary conditions to advance this significant strategic initiative.